Shorla

Shorla Oncology

This company develops and commercialises innovative oncology drugs to treat patients with rare, paediatric and orphan cancers.

Carrick Therapeutics

This biopharmaceutical company develops precision oncology therapies for patients with aggressive cancers, focusing on small molecules and inhibitors for solid tumours.

iOnctura

The company develops precision small-molecule medicines to treat patients with neglected and hard-to-treat solid tumours and cancers.

SpringWorks Therapeutics

This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.

Salarius Pharmaceutical

This company develops epigenetic therapeutics and peptide-conjugate treatments for patients with rare pediatric cancers and advanced solid tumours.

Luminate Medical

This company develops wearable medical devices to prevent chemotherapy side effects and facilitate at-home cancer treatment for oncology patients and healthcare providers.

Sartar Therapeutics

This company develops targeted cancer therapies for patients with gastrointestinal stromal tumours and other soft tissue sarcomas.

Orakl Oncology

This company develops a predictive platform using patient tumor avatars and data to help pharmaceutical firms accelerate and de-risk cancer drug development.